Following the initial finding that human sialidase NEU3 co-immunoprecipitates with EGFR in HeLa cells [20], it has been found that NEU3 is directly involved in EGFR desialylation in colorectal cancer, promoting receptor dimerization, and therefore EGFR activation [21]. Here, NEU3 is linked to colorectal cancer.